FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Uwe Schönbeck

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Andreas Zirlik; Shuaib M Abdullah; Norbert Gerdes; Lindsey MacFarlane; Uwe Schönbeck; Amit Khera; Darren K McGuire; Gloria Lena Vega; Scott Grundy; Peter Libby; James A de Lemos
Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.
Andreas Zirlik; Udo Bavendiek; Peter Libby; Lindsey MacFarlane; Norbert Gerdes; Joanna Jagielska; Sandra Ernst; Masanori Aikawa; Hiroyasu Nakano; Erdyni N Tsitsikov; Uwe Schönbeck
TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
Andreas Zirlik; Christoph Maier; Norbert Gerdes; Lindsey MacFarlane; Juliana Soosairajah; Udo Bavendiek; Ingo Ahrens; Sandra Ernst; Nicole Bassler; Anna Missiou; Zsofia Patko; Masanori Aikawa; Uwe Schönbeck; Christoph Bode; Peter Libby; Karlheinz Peter
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Uwe Schönbeck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Andreas Zirlik; Shuaib M Abdullah; Norbert Gerdes; Lindsey MacFarlane; Uwe Schönbeck; Amit Khera; Darren K McGuire; Gloria Lena Vega; Scott Grundy; Peter Libby; James A de Lemos
Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(9):2043-9.
2007: Andreas Zirlik; Udo Bavendiek; Peter Libby; Lindsey MacFarlane; Norbert Gerdes; Joanna Jagielska; Sandra Ernst; Masanori Aikawa; Hiroyasu Nakano; Erdyni N Tsitsikov; Uwe Schönbeck
TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(5):1101-7.
2007: Andreas Zirlik; Christoph Maier; Norbert Gerdes; Lindsey MacFarlane; Juliana Soosairajah; Udo Bavendiek; Ingo Ahrens; Sandra Ernst; Nicole Bassler; Anna Missiou; Zsofia Patko; Masanori Aikawa; Uwe Schönbeck; Christoph Bode; Peter Libby; Karlheinz Peter
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.
Circulation 2007;115(12):1571-80.
2006: Nerea Varo; Rebecca Nuzzo; Cristina Natal; Peter Libby; Uwe Schönbeck
Influence of pre-analytical and analytical factors on soluble CD40L measurements.
Clinical science (London, England : 1979) 2006;111(5):341-7.
2006: Kikuo Isoda; James L Young; Andreas Zirlik; Lindsey MacFarlane; Naotake Tsuboi; Norbert Gerdes; Uwe Schönbeck; Peter Libby
Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(3):611-7.
2005: James A de Lemos; Andreas Zirlik; Uwe Schönbeck; Nerea Varo; Sabina A Murphy; Amit Khera; Darren K McGuire; Greg Stanek; Hao S Lo; Rebecca Nuzzo; David A Morrow; ronald peshock; Peter Libby
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2192-6.
2005: Udo Bavendiek; Andreas Zirlik; Samantha LaClair; Lindsey MacFarlane; Peter Libby; Uwe Schönbeck
Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(6):1244-9.
2005: Nerea Varo; Peter Libby; Rebecca Nuzzo; Joseph Italiano; Alessandro Doria; Uwe Schönbeck
Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2005;2(2):81-7.
2004: Alexandra Krettek; Galina K Sukhova; Uwe Schönbeck; Peter Libby
Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells.
The American journal of pathology 2004;165(5):1571-81.
2004: Uwe Schönbeck; Peter Libby
Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
Circulation 2004;109(21 Suppl 1):II18-26.
2004: Jan Felix Christiansen; Dirk Hartwig; J F Matthias Bechtel; Harald Klüter; Hans-Hinrich Sievers; Uwe Schönbeck; Claus Bartels
Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteries.
The Annals of thoracic surgery 2004;77(5):1575-9.
2003: Nerea Varo; James A de Lemos; Peter Libby; David A Morrow; Sabina A Murphy; Rebecca Nuzzo; C Michael Gibson; Christopher P Cannon; Eugene Braunwald; Uwe Schönbeck
Soluble CD40L: risk prediction after acute coronary syndromes.
Circulation 2003;108(9):1049-52.
2003: Nerea Varo; David Vicent; Peter Libby; Rebecca Nuzzo; Alfonso L Calle-Pascual; María Rosa Bernal; Arturo Fernández-Cruz; Aristidis Veves; Petr Jarolim; Jose Javier Varo; Allison B Goldfine; Edward S Horton; Uwe Schönbeck
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
Circulation 2003;107(21):2664-9.
2003: Gavin J Blake; Robert J Ostfeld; E Kent Yucel; Nerea Varo; Uwe Schönbeck; Michael A Blake; Marie Gerhard; Paul M Ridker; Peter Libby; Richard T Lee
Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(1):e11-4.
2002: Uwe Schönbeck; Norbert Gerdes; Nerea Varo; Rebecca S Reynolds; Daniel B Horton; Udo Bavendiek; Linda Robbie; Peter Ganz; Scott Kinlay; Peter Libby
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
Circulation 2002;106(23):2888-93.
2002: James L Young; Peter Libby; Uwe Schönbeck
Cytokines in the pathogenesis of atherosclerosis.
Thrombosis and haemostasis 2002;88(4):554-67.
2002: Göran K Hansson; Peter Libby; Uwe Schönbeck; Zhong-Qun Yan
Innate and adaptive immunity in the pathogenesis of atherosclerosis.
Circulation research 2002;91(4):281-91.
2002: Uwe Schönbeck; Galina K Sukhova; Norbert Gerdes; Peter Libby
T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.
The American journal of pathology 2002;161(2):499-506.
2002: Udo Bavendiek; Peter Libby; Meagan Kilbride; Rebecca Reynolds; Nigel Mackman; Uwe Schönbeck
Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1.
The Journal of biological chemistry 2002;277(28):25032-9.
2002: Norbert Gerdes; Galina K Sukhova; Peter Libby; Rebecca S Reynolds; James L Young; Uwe Schönbeck
Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis.
The Journal of experimental medicine 2002;195(2):245-57.
2001: Uwe Schönbeck; Peter Libby
CD40 signaling and plaque instability.
Circulation research 2001;89(12):1092-103.
2001: Uwe Schönbeck; Nerea Varo; Peter Libby; Julie E Buring; Paul M Ridker
Soluble CD40L and cardiovascular risk in women.
Circulation 2001;104(19):2266-8.
2001: M P Herman; Galina K Sukhova; Peter Libby; Norbert Gerdes; N Tang; Daniel B Horton; M Kilbride; R E Breitbart; M Chun; Uwe Schönbeck
Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling.
Circulation 2001;104(16):1899-904.
2001: M P Herman; Galina K Sukhova; W Kisiel; D Foster; M R Kehry; P Libby; Uwe Schönbeck
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.
The Journal of clinical investigation 2001;107(9):1117-26.
2001: Nikolaus Marx; Nigel Mackman; Uwe Schönbeck; N Yilmaz; Vinzenz Hombach; Peter Libby; Jorge Plutzky
PPARalpha activators inhibit tissue factor expression and activity in human monocytes.
Circulation 2001;103(2):213-9.
2001: Uwe Schönbeck; Peter Libby
The CD40/CD154 receptor/ligand dyad.
Cellular and molecular life sciences : CMLS 2001;58(1):4-43.
2000: Peter Libby; Masanori Aikawa; Uwe Schönbeck
Cholesterol and atherosclerosis.
Biochimica et biophysica acta 2000;1529(1-3):299-309.
2000: Uwe Schönbeck; F Mach; P Libby
CD154 (CD40 ligand).
The international journal of biochemistry & cell biology 2000;32(7):687-93.
2000: Uwe Schönbeck; Galina K Sukhova; K Shimizu; F Mach; Peter Libby
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(13):7458-63.
2000: James L Young; G K Sukhova; D Foster; W Kisiel; Peter Libby; Uwe Schönbeck
The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells.
The Journal of experimental medicine 2000;191(9):1535-44.
2000: Uwe Schönbeck; F Mach; Galina K Sukhova; M Herman; P Graber; M R Kehry; Peter Libby
CD40 ligation induces tissue factor expression in human vascular smooth muscle cells.
The American journal of pathology 2000;156(1):7-14.
1999: Uwe Schönbeck; G K Sukhova; P Graber; S Coulter; Peter Libby
Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.
The American journal of pathology 1999;155(4):1281-91.
1999: Peter Libby; F Mach; Uwe Schönbeck; todd bourcier; Masanori Aikawa
Regulation of the thrombotic potential of atheroma.
Thrombosis and haemostasis 1999;82(2):736-41.
1999: Galina K Sukhova; Uwe Schönbeck; Elena Rabkin; Frederick J Schoen; A R Poole; R C Billinghurst; Peter Libby
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques.
Circulation 1999;99(19):2503-9.
1999: Uwe Schönbeck; F Mach; Galina K Sukhova; E Atkinson; E Levesque; M Herman; P Graber; P Basset; Peter Libby
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
The Journal of experimental medicine 1999;189(5):843-53.
1999: F Mach; Uwe Schönbeck; RP Fabunmi; C Murphy; E Atkinson; JY Bonnefoy; P Graber; Peter Libby
T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation.
The American journal of pathology 1999;154(1):229-38.
1998: Nikolaus Marx; Uwe Schönbeck; Mitchell Lazar; Peter Libby; Jorge Plutzky
Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Circulation research 1998;83(11):1097-103.
1998: Uwe Schönbeck; F Mach; Peter Libby
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3340-6.
1998: F Mach; Uwe Schönbeck; Galina K Sukhova; E Atkinson; Peter Libby
Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
Nature 1998;394(6689):200-3.
1998: F Mach; Uwe Schönbeck; Peter Libby
CD40 signaling in vascular cells: a key role in atherosclerosis?
Atherosclerosis 1998;137 Suppl():S89-95.
1998: T Mattern; C Reich; Uwe Schönbeck; S Ansorge; H U Demuth; Harald Loppnow; Artur J Ulmer; Hans-Dieter Flad
CD26 (dipeptidyl peptidase i.v.) on human T lymphocytes does not mediate adhesion of these cells to endothelial cells or fibroblasts.
Immunobiology 1998;198(4):465-75.
1998: Harald Loppnow; R Bil; S Hirt; Uwe Schönbeck; Mona Herzberg; Karl Werdan; Ernst Th Rietschel; Ernst Brandt; Hans-Dieter Flad
Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells.
Blood 1998;91(1):134-41.
1997: Uwe Schönbeck; F Mach; Galina K Sukhova; C Murphy; JY Bonnefoy; RP Fabunmi; Peter Libby
Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?
Circulation research 1997;81(3):448-54.
1997: Uwe Schönbeck; F Mach; J Y Bonnefoy; Harald Loppnow; Hans-Dieter Flad; Peter Libby
Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta.
The Journal of biological chemistry 1997;272(31):19569-74.
1997: F Mach; Uwe Schönbeck; JY Bonnefoy; J S Pober; Peter Libby
Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.
Circulation 1997;96(2):396-9.
1997: Uwe Schönbeck; Mona Herzberg; A Petersen; Claudia Wohlenberg; Johannes Gerdes; Hans-Dieter Flad; Harald Loppnow
Human vascular smooth muscle cells express interleukin-1beta-converting enzyme (ICE), but inhibit processing of the interleukin-1beta precursor by ICE.
The Journal of experimental medicine 1997;185(7):1287-94.
1997: F Mach; Uwe Schönbeck; Galina K Sukhova; todd bourcier; JY Bonnefoy; J S Pober; Peter Libby
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1931-6.
1996: Ernst Th Rietschel; Helmut Brade; Otto Holst; Lore Brade; Sven Müller-Loennies; Uwe Mamat; Ulrich Zähringer; F Beckmann; Ulrich Seydel; Klaus Brandenburg; Artur J Ulmer; T Mattern; Holger Heine; J Schletter; Harald Loppnow; Uwe Schönbeck; Hans-Dieter Flad; Sunna Hauschildt; U F Schade; F Di Padova; S Kusumoto; Ralf R Schumann
Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification.
Current topics in microbiology and immunology 1996;216():39-81.
1995: Uwe Schönbeck; Ernst Brandt; Frank Petersen; Hans-Dieter Flad; Harald Loppnow
IL-8 specifically binds to endothelial but not to smooth muscle cells.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(5):2375-83.
1995: Harald Loppnow; Felix Stelter; Uwe Schönbeck; C Schlüter; Martin Ernst; Christine Schütt; Hans-Dieter Flad
Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.
Infection and immunity 1995;63(3):1020-6.